Cargando…
3'-Ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction
BACKGROUND: We previously reported that 3'-ethynylcytidine (ECyd, TAS-106), an RNA polymerases inhibitor, enhances the anti-tumor efficacy of platinum in several tumor types in both in vitro and in vivo tumor models. However, the molecular mechanisms underlying the ECyd-induced enhancement rema...
Autores principales: | Fukushima, Hiroto, Abe, Tetsuya, Sakamoto, Kazuki, Tsujimoto, Hiroaki, Mizuarai, Shinji, Oie, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131025/ https://www.ncbi.nlm.nih.gov/pubmed/25087851 http://dx.doi.org/10.1186/1471-2407-14-562 |
Ejemplares similares
-
Cellular pharmacology of multi- and duplex drugsconsisting of ethynylcytidine and 5-fluoro-2′-deoxyuridine
por: Bijnsdorp, Irene V., et al.
Publicado: (2009) -
ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells
por: Fukushima, Hiroto, et al.
Publicado: (2016) -
Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
por: Mizuarai, Shinji, et al.
Publicado: (2009) -
Can Systems Biology Understand Pathway Activation? Gene Expression Signatures as Surrogate Markers for Understanding the Complexity of Pathway Activation
por: Itadani, Hiraku, et al.
Publicado: (2008) -
Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma
por: Cui, Jinfang, et al.
Publicado: (2023)